Titles: Surge in Research & Development Activities Boosts Global Cell Lines Market
The global cell lines market is expected to ride on the back of surging applications in research, especially in biochemistry, cell biology, cancer diagnostics, drug discovery and molecular biology. A few of the aspects which have a direct positive influence on the cell lines market include
- Development of novel technologies have ensued in expanding the usage to recognise and treat several ailments
- Extensive usage of cell lines in drug discovery
- Increased investment in research and development
- Cell lines are being widely utilized to treat cancer as the number of cases of cancer is surging in both emerging and developed economies
Request Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=180
The cancer cell lines are gaining traction and are projected to sustain their segment’s lucrativeness over other product types amid the assessment period. Subsequent to this, the immunotherapy cell lines reflects a relatively high market revenue share as compared to other products. On the other hand, ion channel cell lines will be reflecting higher growth pace compared to other product segments to record a CAGR of 3.8% amid the forecast period of 2017 to 2022.
A per the research report published by Fact.MR’s on the global cell lines market, the market is slated to reflect a moderate expansion rate amid the assessment period of 2017-2022 and is likely to account for an estimation of over US$ 140 Mn. The global market is influenced by various benefits that the cell liens provide, which incorporate cost effectiveness, ease in use, in addition to they offer pure cells which are required to get reproducible results together with consistent samples.
How will Increase in Chronic Ailments Influence Cell Lines Demand?
Majority of the biopharma player utilize cells lines as an expression host for recombinant monoclonal antibody manufacturing. Rise in demand for cancer therapeutics, monoclonal antibodies, and the accessibility of innovative technologies to manufacture novel cell lines are projected to thrust the market growth in the forthcoming years.
Additionally, increase in the biosimilars production owing to patent expiry of recombinant proteins and branded therapeutics is projected to increase the demand. Rising chronic ailments prevalence demands efficient treatment solutions thus fuels the demand to manufacture novel drugs, therapeutic proteins, vaccines, and biosimilars amid the forecast period.
For instance, the human cell lines utilized for vaccine manufacturing are WI-38 cell line developed in the United States., as well as MRC-5 cell line manufactured in the U.K. The vaccines formulated by utilizing animal cells are employed for the treatment of Japanese encephalitis, smallpox, rotavirus, and polio. The vaccines manufactured incorporate rubella, hepatitis A, varicella, adenovirus type 4 & 7 oral, zoster, along with rabies.
Explore 276 tables and 102 figures in the study. Request ToC of the report at-
The United States has an advanced healthcare infrastructure, in contrast to majority of the developed nations. The existence of majority of the players in the United States is the key aspect propelling the expansion of the market studied in the region. Additionally, backing from the US government to fast-track the research in the biopharmaceutical and biotechnology sector has been expanding the demand for cell lines.
Increase in Investment in R&D
Driven by high demand in the US, North America will continue to be one of the most lucrative markets for cell lines globally. The North America cell lines market is poised to expand at a 3.3% CAGR amid the assessment period of 2017 to 2022. The key attribute to the growth is the progressions in technology in this region. This, combined with a rise in the investment made on the R&D only adds to the lucrative attribute of North America region. Increase in innovations in drug delivery together with growing biopharmaceutical companies and research and academic institutes in North America add to the expansion in the usage of cell lines in this region, therefore making it more noteworthy.
Explore Fact.MR's Comprehensive Coverage on Healthcare Landscape
Rheumatoid Arthritis Stem Cell Therapy Market - On the back of the increasing popularity across specialty clinics, ambulatory surgical centers, and, hospitals, a recent study by Fact.MR foretells that, the rheumatoid arthritis stem cell therapy market would record a value around to US$ 12 Bn towards 2027 end.
Epidermal Cell sheets Market - Restricted lifespan of the products, higher cost associated with the product procedure, and risk related to the epidermal cell sheets are the key obstacle to the market expansion of epidermal cell sheets.
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai, United Arab Emirates
MARKET ACCESS DMCC Initiative